|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
16
|
|
pubmed:dateCreated |
2005-10-17
|
|
pubmed:abstractText |
To investigate whether and how mutations at position 89 of HIV-1 protease were associated with protease inhibitor (PI) failure, and what is the impact of the HIV-1 subtype.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0269-9370
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
4
|
|
pubmed:volume |
19
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1799-806
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16227787-Adult,
pubmed-meshheading:16227787-Amino Acid Sequence,
pubmed-meshheading:16227787-Bayes Theorem,
pubmed-meshheading:16227787-Drug Resistance, Multiple, Viral,
pubmed-meshheading:16227787-Female,
pubmed-meshheading:16227787-Genotype,
pubmed-meshheading:16227787-HIV Infections,
pubmed-meshheading:16227787-HIV Protease,
pubmed-meshheading:16227787-HIV Protease Inhibitors,
pubmed-meshheading:16227787-HIV-1,
pubmed-meshheading:16227787-Humans,
pubmed-meshheading:16227787-Male,
pubmed-meshheading:16227787-Mutation,
pubmed-meshheading:16227787-Phenotype,
pubmed-meshheading:16227787-Treatment Failure,
pubmed-meshheading:16227787-Viral Load
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Protease mutation M89I/V is linked to therapy failure in patients infected with the HIV-1 non-B subtypes C, F or G.
|
|
pubmed:affiliation |
Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium. ana.abecasis@uz.kuleuven.ac.be
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
